Solubility Enhancement of Cefdinir using different Pharmaceutical Approaches for Enhancement of the Drug Performance
DOI:
https://doi.org/10.31351/vol34iss1pp122-132Abstract
Cefdinir (CEF) is classified as a third-generation cephalosporin within class IV of the Biopharmaceutical Classification System (BCS). Consequently, it exhibits limited solubility in water, which might diminished oral bioavailability. This study aimed to compare CEF in different engineered product. Specifically, the CEF was physically mixed with co-former and then processed using different methods such as co-amorphous system formation with curcumin, binary solid dispersion with polyvinylpyrrolidone k30 (PVP) and with soluplus and ternary solid dispersion with curcumin and PVP using solvent evaporation method. The products were subjected to characterization using Differential Scanning Calorimetry (DSC), Powder X-ray Diffractometry (PXRD), and Fourier Transform Infrared Spectroscopy (FTIR). Additionally, dissolution and antibacterial activity tests were performed on these systems. The findings indicate a decrease in crystallinity for both curcumin and soluplus binary systems. Conversely, in the case of CEF with PVP binary SD and ternary SD with curcumin, the results demonstrate the entire creation of an amorphous system, resulting in improved release and antibacterial properties compared to the pure drug. The presence of PVP in the solvent evaporated product in both binary and ternary product produce a miscible mix which might correlated to this totally amorphous solid dispersed system.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Kiyonga EM, Kekani LN, Chidziwa TV, Kahwenga KD, Bronkhorst E, Milne M, et al. Nano-and Crystal Engineering Approaches in the Development of Therapeutic Agents for Neoplastic Diseases. Crystals. 2022;12(7):926.
Tran P, Pyo Y-C, Kim D-H, Lee S-E, Kim J-K, Park J-S. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132.
Sarpal K, Munson EJ. Amorphous solid dispersions of felodipine and nifedipine with Soluplus®: drug-polymer miscibility and intermolecular interactions. Journal of Pharmaceutical Sciences. 2021;110(4):1457-69.
Song B, Wang J, Lu SJ, Shan LN. Andrographolide solid dispersions formulated by Soluplus to enhance interface wetting, dissolution, and absorption. Journal of Applied Polymer Science. 2020;137(6):48354.
Mizoguchi R, Waraya H, Hirakura Y. Application of co-amorphous technology for improving the physicochemical properties of amorphous formulations. Molecular pharmaceutics. 2019;16(5):2142-52.
Fang X, Hu Y, Yang G, Shi W, Lu S, Cao Y. Improving physicochemical properties and pharmacological activities of ternary co-amorphous systems. European Journal of Pharmaceutics and Biopharmaceutics. 2022;181:22-35.
Hashim G, Hameed G, Hanna D. Improving the Dissolution Rate and the Bioavailability of Favipiravir by Solid Dispersion with Curcumin. Latin American Journal of Pharmacy. 2023:68-76.
Dinç E, Dermiş S, Can Akcasoy S, Ceren Ertekin Z. A New Chemometric strategy in electrochemical method optimization for the quantification of cefdinir in tablets, effervescent tablets and suspension samples. Electroanalysis. 2020;32(3):613-9.
Sawant KK, Patel MH, Patel K. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro–in vivo evaluations. Drug development and industrial pharmacy. 2016;42(5):758-68.
Al Okla S, Prashanth GP, Kurbet S, Al Attraqchi Y, Asaad A. Emergent “Bloody Diarrhea” Associated with the Use of Oral Cefdinir in Young Children: A Brief Report and Review of Literature. The Journal of Emergency Medicine. 2023.
Al Nuss R. pH-Modified Solid Dispersions of Cefdinir for Dissolution Rate Enhancement: Formulation and Characterization. J Pharm Nutr Sci. 2021;11:101-15.
Al-Badr AA, Alasseiri FA. Cefdinir. Profiles of Drug Substances, Excipients and Related Methodology. 2014;39:41-112.
Jung D-H, Song JG, Han H-K. Development and evaluation of a sustained release solid dispersion of cefdinir using a hydrophobic polymeric carrier and aminoclay. Journal of Drug Delivery Science and Technology. 2023;84:104503.
Park J, Park HJ, Cho W, Cha K-H, Kang Y-S, Hwang S-J. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process. International journal of pharmaceutics. 2010;396(1-2):239-45.
Jain S, Jain S, Mishra A, Garg G, Modi RK. Formulation and characterization of fast disintegrating tablets containing Cefdinir solid dispersion. International Journal of Pharmacy & Life Sciences. 2012;3(12).
Bansal S, Aggarwal G, Chandel P, Harikumar S. Design and development of cefdinir niosomes for oral delivery. Journal of pharmacy & bioallied sciences. 2013;5(4):318.
Aleem O, Kuchekar B, Pore Y, Late S. Effect of β-cyclodextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. Journal of pharmaceutical and biomedical analysis. 2008;47(3):535-40.
Bali DE, Arafa MF, Gamaleldin NM, El Maghraby GM. Nanographene oxide for enhanced dissolution rate and antibacterial activity of cefdinir. Journal of Drug Delivery Science and Technology. 2021;62:102411.
Leonardi D, Salomon CJ. Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets. Journal of pharmaceutical sciences. 2013;102(3):1016-23.
Arora S, Sharma P, Irchhaiya R, Khatkar A, Singh N, Gagoria J. Development, characterization and solubility study of solid dispersions of cefuroxime axetil by the solvent evaporation method. Journal of Advanced Pharmaceutical Technology & Research. 2010;1(3):326.
Douroumis D, Bouropoulos N, Fahr A. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method. Journal of pharmacy and pharmacology. 2007;59(5):645-53.
Tabbakhian M, Hasanzadeh F, Tavakoli N, Jamshidian Z. Dissolution enhancement of glibenclamide by solid dispersion: solvent evaporation versus a supercritical fluid-based solvent-antisolvent technique. Research in pharmaceutical sciences. 2014;9(5):337.
Panghal D, Nagpal M, Thakur GS, Arora S. Dissolution improvement of atorvastatin calcium using modified locust bean gum by the solid dispersion technique. Scientia pharmaceutica. 2014;82(1):177-92.
Leyva-Porras C, Cruz-Alcantar P, Espinosa-Solís V, Martínez-Guerra E, Piñón-Balderrama CI, Compean Martínez I, et al. Application of differential scanning calorimetry (DSC) and modulated differential scanning calorimetry (MDSC) in food and drug industries. Polymers. 2019;12(1):5.
Ali SK, Al-Khedairy EB. Solubility and dissolution enhancement of atorvastatin calcium using solid dispersion adsorbate technique. Iraqi J Pharm Sci. 2019;28(2):105-14.
Abd-AlRazaq IF, Rahi FA, Al-lami MS. Preparation And Characterization Of Nimesulide Nanoparticles For Dissolution Improvement. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2018;18(1):46-60.
Jaiswar DR, Jha D, Amin PD. Preparation and characterizations of stable amorphous solid solution of azithromycin by hot melt extrusion. Journal of Pharmaceutical Investigation. 2016;46:655-68.
Rao MR, Chaudhari J, Trotta F, Caldera F. Investigation of cyclodextrin-based nanosponges for solubility and bioavailability enhancement of rilpivirine. Aaps Pharmscitech. 2018;19:2358-69.
Tawfeeq TA, Jasim GA, Nasser AA. Isolation of umbelliferone from leaves of Conocarpus erectus L. cultivated in Iraq. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2020;20(4):82-92.
Nagaraj K, Narendar D, Kishan V. Development of olmesartan medoxomil optimized nanosuspension using the Box–Behnken design to improve oral bioavailability. Drug development and industrial pharmacy. 2017;43(7):1186-96.
Gadhiya DT, Patel JK, Bagada AA. An impact of nanocrystals on dissolution rate of Lercanidipine: Supersaturation and crystallization by addition of solvent to antisolvent. Future Journal of Pharmaceutical Sciences. 2021;7:1-17.
Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S. The science of USP 1 and 2 dissolution: present challenges and future relevance. Pharmaceutical research. 2009;26:1289-302.
Praveen R, Verma PRP, Singh SK, George JK. Cross linked alginate gel beads as floating drug delivery system for cefdinir: optimization using Box–Behnken design. Journal of pharmaceutical investigation. 2015;45:187-99.
Malik MM, Maraie NK. Preparation and evaluation of famotidine nanosuspension. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2018;18(2):13-23.
Alhasan DA. In Vitro Antimicrobial Activity of Curcumin-Copper Complex. University of Thi-Qar Journal. 2021;16(1):73-97.
Ali ZA, Jasim TM, Alani WM. Antibacterial activity of chloroform extract from Tagetes Erecta L. flowers. Al Mustansiriyah Journal of Pharmaceutical Sciences. 2019;19(4):7-15.
Morina D, Sessevmez M, Sinani G, Mülazımoğlu L, Cevher E. Oral tablet formulations containing cyclodextrin complexes of poorly water soluble cefdinir to enhance its bioavailability. Journal of Drug Delivery Science and Technology. 2020;57:101742.
Guo B, Zhong S, Li N, Li X, Yi J, Jin M. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin. Drug Development and Industrial Pharmacy. 2013;39(11):1638-43.
ISMAEL QA, HAMEED GS, AZIZ FM. Effect of Introduction of Polymers on the Antibacterial Activity of Crystalline Antibiotics. International Journal of Pharmaceutical Research (09752366). 2020;12(3).
Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions. International journal of pharmaceutics. 2019;554:190-200.
Nowak P, Krupa A, Kubat K, Węgrzyn A, Harańczyk H, Ciułkowska A, et al. Water vapour sorption in tadalafil-Soluplus co-milled amorphous solid dispersions. Powder Technology. 2019;346:373-84.
Fan W, Zhu W, Zhang X, Di L. The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot Melt Extrusion—Ⅰ. Optimization of the Formulation. Journal of Pharmaceutical Sciences. 2020;109(3):1242-52.
Mustafa WW, Fletcher J, Khoder M, Alany RG. Solid dispersions of gefitinib prepared by spray drying with improved mucoadhesive and drug dissolution properties. AAPS PharmSciTech. 2022;23(1):48.
Cho H-J, Jee J-P, Kang J-Y, Shin D-Y, Choi H-G, Maeng H-J, et al. Cefdinir solid dispersion composed of hydrophilic polymers with enhanced solubility, dissolution, and bioavailability in rats. Molecules. 2017;22(2):280.
Choi J-S, Park J-S. Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. European journal of pharmaceutical sciences. 2017;97:269-76.
Yu C, Zhang C, Guan X, Yuan D. The solid dispersion of resveratrol with enhanced dissolution and good system physical stability. Journal of Drug Delivery Science and Technology. 2023;84:104507.
Chen J, Li H, Li X, Yuan D, Cheng H, Ke Y, et al. Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms. European Journal of Pharmaceutics and Biopharmaceutics. 2022;178:82-93.
Han J, Li L, Su M, Heng W, Wei Y, Gao Y, et al. Deaggregation and crystallization inhibition by small amount of polymer addition for a co-amorphous curcumin-magnolol system. Pharmaceutics. 2021;13(10):1725.
Wang B, Wang D, Zhao S, Huang X, Zhang J, Lv Y, et al. Evaluate the ability of PVP to inhibit crystallization of amorphous solid dispersions by density functional theory and experimental verify. European Journal of Pharmaceutical Sciences. 2017;96:45-52.
Bejaoui M, Galai H, Amara ABH, Ben Rhaiem H. Formation of water soluble and stable amorphous ternary system: ibuprofen/β-cyclodextrin/PVP. Glass Physics and Chemistry. 2019;45:580-8.
Mendes C, Valentini G, Chamorro Rengifo AF, Pinto JM, Silva MA, Parize AL. Supersaturating drug delivery system of fixed drug combination: sulfamethoxazole and trimethoprim. Expert review of anti-infective therapy. 2019;17(10):841-50.
Mesallati H, Umerska A, Paluch KJ, Tajber L. Amorphous polymeric drug salts as ionic solid dispersion forms of ciprofloxacin. Molecular pharmaceutics. 2017;14(7):2209-23.
Yurtdaş-Kırımlıoğlu G. Development and characterization of lyophilized cefpodoxime proxetil-Pluronic® F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity. Pharmaceutical Development and Technology. 2021;26(4):476-89.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
